These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2202067)

  • 1. [The intradialytic kinetics of uremic toxins in the diffusion-convection hemodialysis method].
    Navino C; Barbè MC; Chiarinotti D; Guida GE; Cusaro C; Fortina A; De Leo M; Pecora S; Verzetti G
    Minerva Urol Nefrol; 1990; 42(1):13-6. PubMed ID: 2202067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [On-line haemodiafiltration with sorbent-regenerated ultrafiltrate as replacement fluid: Beta2-microglobulin removal versus filtration fraction].
    Emiliani G; Briganti M; Montanari A; Isola E; Fusaroli M
    G Ital Nefrol; 2004; 21 Suppl 30():S80-4. PubMed ID: 15747312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convective therapies for removal of middle molecular weight uremic toxins in end-stage renal disease: a review of the evidence.
    Thomas G; Jaber BL
    Semin Dial; 2009; 22(6):610-4. PubMed ID: 20017830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paired filtration-dialysis (PFD): a separate convective-diffusive system for extracorporeal blood purification in uraemic patients.
    Ghezzi PM; Zucchelli P; Ringoir S; Nigrelli S; Santoro A; Gervasio R; Sanz Moreno C; Vanholder R; Botella J
    Adv Exp Med Biol; 1987; 223():267-75. PubMed ID: 3328955
    [No Abstract]   [Full Text] [Related]  

  • 5. [Quantifying dialysis efficiency for middle molecules in haemodialysis and in convective and mixed techniques].
    Casino FG; Lopez T
    G Ital Nefrol; 2008; 25(1):66-75. PubMed ID: 18264920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [What does circulating beta 2 microglobulin signify in uremic patients on maintenance dialysis?].
    Assounga A; Canaud B; Flavier JL; Slingeneyer A; Robinet-Lévy M; Aznar R; Mion C
    Nephrologie; 1987; 8(6):301-6. PubMed ID: 3330579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Principles and practice of hemofiltration and hemodiafiltration.
    Ledebo I
    Artif Organs; 1998 Jan; 22(1):20-5. PubMed ID: 9456222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetate-free biofiltration: hemodiafiltration with base-free dialysate.
    Zucchelli P; Santoro A; Ferrari G; Spongano M
    Blood Purif; 1990; 8(1):14-22. PubMed ID: 2378708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the effects of low dialysate flow rates on removal rates and clearance using high flux membranes.
    Park KI; Tomoyoshi T
    Blood Purif; 1997; 15(3):208-12. PubMed ID: 9262848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical Method and Biochemical Source for the Assessment of the Middle-Molecule Uremic Toxin β2-Microglobulin in Spent Dialysate.
    Paats J; Adoberg A; Arund J; Fridolin I; Lauri K; Leis L; Luman M; Tanner R
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of on-line conductivity plasma ultrafiltrate kinetic modeling on cardiovascular stability of hemodialysis patients.
    Locatelli F; Andrulli S; Di Filippo S; Redaelli B; Mangano S; Navino C; Ariano R; Tagliaferri M; Fidelio T; Corti M; Civardi S; Tetta C
    Kidney Int; 1998 Apr; 53(4):1052-60. PubMed ID: 9551417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodiafiltration without replacement fluid. An experimental study.
    Ghezzi PM; Gervasio R; Tessore V; Sartoris AM; Botella J
    ASAIO J; 1992; 38(1):61-5. PubMed ID: 1554919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intradialytic kinetics of middle molecules during hemodialysis and hemodiafiltration.
    Leypoldt JK; Storr M; Agar BU; Boschetti-de-Fierro A; Bernardo AA; Kirsch AH; Rosenkranz AR; Krieter DH; Krause B
    Nephrol Dial Transplant; 2019 May; 34(5):870-877. PubMed ID: 30307514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPLC study of uremic fluids related to optical dialysis adequacy monitoring.
    Lauri K; Tanner R; Jerotskaja J; Luman M; Fridolin I
    Int J Artif Organs; 2010 Feb; 33(2):96-104. PubMed ID: 20306436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of intradialytic exercise on hemodialysis adequacy: A systematic review.
    Kirkman DL; Scott M; Kidd J; Macdonald JH
    Semin Dial; 2019 Jul; 32(4):368-378. PubMed ID: 30968465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term evaluation of charcoal hemoperfusion combined with dialysis in uremic patients.
    Winchester JF; Apiliga MT; Kennedy AC
    Kidney Int Suppl; 1976 Dec; (7):S315-9. PubMed ID: 1070554
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biofiltration without buffering substances in the dialysate].
    Quarello F; Boero R; Martina G; Formica M; Guarena C; Beltrame G; Scalzo B; Forneris G; Piccoli G
    Minerva Urol Nefrol; 1990; 42(1):43-6. PubMed ID: 2167517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of uraemic retention solutes in standard bicarbonate haemodialysis and long-hour slow-flow bicarbonate haemodialysis.
    Basile C; Libutti P; Di Turo AL; Casino FG; Vernaglione L; Tundo S; Maselli P; De Nicolò EV; Ceci E; Teutonico A; Lomonte C
    Nephrol Dial Transplant; 2011 Apr; 26(4):1296-303. PubMed ID: 20813765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the ultrafiltrate obtained in two-chamber (PFD) hemodiafiltration as replacement fluid. Experimental ex vivo and in vitro study.
    Ghezzi PM; Botella J; Sartoris AM; Gervasio R; Diez C
    Int J Artif Organs; 1991 Jun; 14(6):327-34. PubMed ID: 1885239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Middle molecules removal. Beyond beta2-microglobulin].
    Maduell F; Sánchez-Canel JJ; Blasco JA; Navarro V; Ríus A; Torregrosa E; Pin MT; Cruz C; Ferrero JA
    Nefrologia; 2006; 26(4):469-75. PubMed ID: 17058859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.